• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西班牙三级新生儿重症监护病房当前护理实践中,呼吸窘迫综合征早产儿早期无创通气失败的前瞻性观察研究

Failure of early non-invasive ventilation in preterm infants with respiratory distress syndrome in current care practice in Spanish level-III neonatal intensive care units - a prospective observational study.

作者信息

Boix Hector, Fernández Cristina, Serrano Martín María Del Mar, Arruza Luis, Concheiro Ana, Gimeno Ana, Sánchez Ana, Rite Segundo, Jiménez Francisco, Méndez Paula, Agüera Juan José

机构信息

Division of Neonatology, Hospital Universitario Dexeus, Barcelona, Spain.

Department of Neonatology, Hospital Universitario Vall d'Hebron, Barcelona, Spain.

出版信息

Front Pediatr. 2023 Feb 21;11:1098971. doi: 10.3389/fped.2023.1098971. eCollection 2023.

DOI:10.3389/fped.2023.1098971
PMID:36896404
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9989254/
Abstract

INTRODUCTION

Despite advances in respiratory distress syndrome (RDS) management over the past decade, non-invasive ventilation (NIV) failure is frequent and associated with adverse outcomes. There are insufficient data on the failure of different NIV strategies currently used in clinical practice in preterm infants.

METHODS

This was a prospective, multicenter, observational study of very preterm infants [gestational age (GA) <32 weeks] admitted to the neonatal intensive care unit for RDS that required NIV from the first 30 min after birth. The primary outcome was the incidence of NIV failure, defined as the need for mechanical ventilation for <72 h of life. Secondary outcomes were risk factors associated with NIV failure and complication rates.

RESULTS

The study included 173 preterm infants with a median GA of 28 (IQR 27-30) weeks and a median birth weight of 1,100 (IQR 800-1,333) g. The incidence of NIV failure was 15.6%. In the multivariate analysis, lower GA (OR, 0.728; 95% CI, 0.576-0.920) independently increased the risk of NIV failure. Compared to NIV success, NIV failure was associated with higher rates of unfavorable outcomes, including pneumothorax, intraventricular hemorrhage, periventricular leukomalacia, pulmonary hemorrhage, and a combined outcome of moderate-to-severe bronchopulmonary dysplasia or death.

CONCLUSION

NIV failure occurred in 15.6% of the preterm neonates and was associated with adverse outcomes. The use of LISA and newer NIV modalities most likely accounts for the reduced failure rate. Gestational age remains the best predictor of NIV failure and is more reliable than the fraction of inspired oxygen during the first hour of life.

摘要

引言

尽管在过去十年中呼吸窘迫综合征(RDS)的管理取得了进展,但无创通气(NIV)失败仍很常见,并与不良后果相关。目前临床实践中用于早产儿的不同NIV策略失败的数据不足。

方法

这是一项对入住新生儿重症监护病房因RDS在出生后最初30分钟内需要NIV的极早产儿[胎龄(GA)<32周]进行的前瞻性、多中心、观察性研究。主要结局是NIV失败的发生率,定义为出生后<72小时需要机械通气。次要结局是与NIV失败相关的危险因素和并发症发生率。

结果

该研究纳入了173例早产儿,中位GA为28(IQR 27 - 30)周,中位出生体重为1100(IQR 800 - 1333)g。NIV失败的发生率为15.6%。在多变量分析中,较低的GA(OR,0.728;95% CI,0.576 - 0.920)独立增加了NIV失败的风险。与NIV成功相比,NIV失败与更高的不良结局发生率相关,包括气胸、脑室内出血、脑室周围白质软化、肺出血以及中重度支气管肺发育不良或死亡的综合结局。

结论

15.6%的早产儿发生了NIV失败,并与不良后果相关。使用肺内表面活性物质注入-表面活性剂后复苏技术(LISA)和更新的NIV模式最有可能是失败率降低的原因。胎龄仍然是NIV失败的最佳预测指标,比出生后第一小时的吸入氧分数更可靠。

相似文献

1
Failure of early non-invasive ventilation in preterm infants with respiratory distress syndrome in current care practice in Spanish level-III neonatal intensive care units - a prospective observational study.西班牙三级新生儿重症监护病房当前护理实践中,呼吸窘迫综合征早产儿早期无创通气失败的前瞻性观察研究
Front Pediatr. 2023 Feb 21;11:1098971. doi: 10.3389/fped.2023.1098971. eCollection 2023.
2
A multicenter, randomized controlled, non-inferiority trial, comparing nasal continuous positive airway pressure with nasal intermittent positive pressure ventilation as primary support before minimally invasive surfactant administration for preterm infants with respiratory distress syndrome (the NIV-MISA-RDS trial): Study protocol.一项多中心、随机对照、非劣效性试验,比较鼻持续气道正压通气与鼻间歇正压通气作为呼吸窘迫综合征早产儿微创表面活性剂给药前的主要支持手段(NIV-MISA-RDS试验):研究方案。
Front Pediatr. 2022 Jul 29;10:968462. doi: 10.3389/fped.2022.968462. eCollection 2022.
3
Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.经鼻给予肺表面活性物质与气管内给予肺表面活性物质后行小潮气量通气治疗中国呼吸窘迫综合征早产儿的随机对照试验研究方案
Trials. 2020 Jun 11;21(1):516. doi: 10.1186/s13063-020-04390-3.
4
[Risk factors for initial non-invasive ventilation failure in very low birth weight infants with gestational age <32 weeks: a multicenter retrospective study].胎龄<32周极低出生体重儿初始无创通气失败的危险因素:一项多中心回顾性研究
Zhongguo Dang Dai Er Ke Za Zhi. 2024;26(9):907-913. doi: 10.7499/j.issn.1008-8830.2404166.
5
Factors Associated With Failure of Non-invasive Ventilation in Preterm Neonates Requiring Initial Respiratory Support.需要初始呼吸支持的早产儿无创通气失败的相关因素。
Cureus. 2024 Feb 8;16(2):e53879. doi: 10.7759/cureus.53879. eCollection 2024 Feb.
6
[Failure of non-invasive continuous positive airway pressure as the initial respiratory support in very preterm infants: a multicenter prospective cohort study].[无创持续气道正压通气作为极早产儿初始呼吸支持的失败:一项多中心前瞻性队列研究]
Zhonghua Er Ke Za Zhi. 2021 Apr 2;59(4):273-279. doi: 10.3760/cma.j.cn112140-20201117-01034.
7
8
Incidence, Predictors and Outcomes of Noninvasive Ventilation Failure in Very Preterm Infants.极早产儿无创通气失败的发生率、预测因素及结局
Children (Basel). 2022 Mar 17;9(3):426. doi: 10.3390/children9030426.
9
Predictors of CPAP failure after less-invasive surfactant administration in preterm infants.早产儿微创表面活性剂给药后持续气道正压通气失败的预测因素。
Front Pediatr. 2024 Aug 27;12:1444906. doi: 10.3389/fped.2024.1444906. eCollection 2024.
10
Three-year perinatal outcomes of less invasive beractant administration in preterm infants with respiratory distress syndrome.早产儿呼吸窘迫综合征患者中应用 less invasive beractant 治疗的 3 年围产期结局。
J Matern Fetal Neonatal Med. 2020 Aug;33(16):2704-2710. doi: 10.1080/14767058.2018.1557633. Epub 2019 Jan 7.

引用本文的文献

1
[Risk factors for initial non-invasive ventilation failure in very low birth weight infants with gestational age <32 weeks: a multicenter retrospective study].胎龄<32周极低出生体重儿初始无创通气失败的危险因素:一项多中心回顾性研究
Zhongguo Dang Dai Er Ke Za Zhi. 2024;26(9):907-913. doi: 10.7499/j.issn.1008-8830.2404166.
2
Predictors of CPAP failure after less-invasive surfactant administration in preterm infants.早产儿微创表面活性剂给药后持续气道正压通气失败的预测因素。
Front Pediatr. 2024 Aug 27;12:1444906. doi: 10.3389/fped.2024.1444906. eCollection 2024.
3
Establishment and Validation of a Risk Prediction Model for Non-Invasive Ventilation Failure After Birth in Premature Infants with Gestational Age < 32 Weeks.

本文引用的文献

1
FiO Before Surfactant, but Not Time to Surfactant, Affects Outcomes in Infants With Respiratory Distress Syndrome.在使用表面活性剂之前的吸氧浓度(FiO₂),而非使用表面活性剂的时间,会影响呼吸窘迫综合征婴儿的预后。
Front Pediatr. 2021 Oct 4;9:734696. doi: 10.3389/fped.2021.734696. eCollection 2021.
2
Prophylactic or very early initiation of continuous positive airway pressure (CPAP) for preterm infants.预防性或极早期开始持续气道正压通气(CPAP)治疗早产儿。
Cochrane Database Syst Rev. 2021 Oct 18;10(10):CD001243. doi: 10.1002/14651858.CD001243.pub4.
3
Indications for and Risks of Noninvasive Respiratory Support.
建立并验证一个预测胎龄 < 32 周早产儿出生后无创通气失败的风险预测模型。
Lung. 2024 Oct;202(5):543-552. doi: 10.1007/s00408-024-00727-w. Epub 2024 Jul 3.
无创呼吸支持的适应证和风险。
Neonatology. 2021;118(2):235-243. doi: 10.1159/000515818. Epub 2021 Apr 26.
4
Examining Variations in Surfactant Administration (ENVISION): A Neonatology Insights Pilot Project.检查表面活性剂给药的差异(ENVISION):一项新生儿学见解试点项目。
Children (Basel). 2021 Mar 28;8(4):261. doi: 10.3390/children8040261.
5
Predictors of CPAP Failure - 10 years' Data of Multiple Trials from a Single Center: A Retrospective Observational Study.CPAP 失败的预测因素——单中心多项试验 10 年数据:一项回顾性观察研究。
Indian J Pediatr. 2020 Nov;87(11):891-896. doi: 10.1007/s12098-020-03399-5. Epub 2020 Jul 6.
6
Fraction of Inspired Oxygen as a Predictor of CPAP Failure in Preterm Infants with Respiratory Distress Syndrome: A Prospective Multicenter Study.吸氧分数预测早产儿呼吸窘迫综合征患者 CPAP 失败的前瞻性多中心研究。
Neonatology. 2019;116(2):171-178. doi: 10.1159/000499674. Epub 2019 May 21.
7
Early predictors of continuous positive airway pressure failure in preterm neonates.早产儿经鼻持续气道正压通气失败的早期预测指标。
J Perinatol. 2019 Aug;39(8):1081-1088. doi: 10.1038/s41372-019-0392-z. Epub 2019 May 14.
8
Non-Invasive Ventilation in Neonatology.新生儿学中的无创通气。
Dtsch Arztebl Int. 2019 Mar 8;116(11):177-183. doi: 10.3238/arztebl.2019.0177.
9
European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2019 Update.欧洲呼吸窘迫综合征管理共识指南-2019 更新版。
Neonatology. 2019;115(4):432-450. doi: 10.1159/000499361. Epub 2019 Apr 11.
10
Preventing Continuous Positive Airway Pressure Failure: Evidence-Based and Physiologically Sound Practices from Delivery Room to the Neonatal Intensive Care Unit.预防持续气道正压通气失败:从产房到新生儿重症监护病房基于证据且符合生理原理的实践方法
Clin Perinatol. 2018 Jun;45(2):257-271. doi: 10.1016/j.clp.2018.01.011. Epub 2018 Feb 28.